Log in to save to my catalogue

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_529ee5858b424de6b4b551d4e3d1d450

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

About this item

Full title

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Publisher

England: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2019-01, Vol.7 (1), p.10-19, Article 10

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chemoradiotherapy (CRT) remains one of the most common cancer treatment modalities, and recent data suggest that CRT is maximally effective when there is generation of an anti-tumoral immune response. However, CRT has also been shown to promote immunosuppressive mechanisms which must be blocked or reversed to maximize its immune stimulating effects...

Alternative Titles

Full title

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_529ee5858b424de6b4b551d4e3d1d450

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_529ee5858b424de6b4b551d4e3d1d450

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-018-0485-9

How to access this item